Andere talen Cereno Scientific AB

Aandelen

CRNO B

SE0008241558

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:29:50 15-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,72 ^SEK	+1,09%		-4,71%	-18,69%

02/05	Cereno Scientific AB (Publ) kondigt benoemingen aan van het benoemingscomité in de aanloop naar de jaarlijkse algemene vergadering van 2025	CI
16/04	Cereno Scientific AB (Publ) keurt verkiezing van nieuwe bestuurders goed	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cereno Scientific to present preclinical data for drug candidate CS585 at the EHA 2024 Hybrid Congress	09:07
Cereno Scientific: Nomination committee appointed ahead of annual general meeting 2025	02/05
Cereno Scientific AB Announces Nomination Committee Appointments Ahead of Annual General Meeting 2025	02/05
Report from Annual General Meeting 2024 of Cereno Scientific AB	16/04
Cereno Scientific AB Approves Election of New Directors	16/04
Cereno Scientific Secures Patent Expansion in Canada for Hypertension Drug Candidate	11/04
Cereno Scientific expands patent protection for epigenetic HDAC inhibitor CS1:s second patent family	11/04
Cereno Scientific Files Clinical Trial Application for Blood Cut Treatment	10/04
Cereno Scientific submits Clinical Trial Application (CTA) for first-in-human Phase I study with novel epigenetic HDACi drug candidate CS014	10/04
Cereno Scientific AB Submits Clinical Trial Application for First-In-Human Phase I Study with Novel Epigenetic HDACi Drug Candidate CS014	10/04
Cereno Scientific Receives Patent Expansion in Europe	09/04
Cereno Scientific announces extended patent protection in Europe for CS585 program	09/04
Cereno Scientific releases Insights Video Season 3 Episode 9 with Dr. Björn Dahlöf, CSO, Cereno Scientific	03/04
Cereno Scientific participates at the ISHLT 44th Annual meeting and Scientific sessions to expand network and meet with investigators for the Phase II Study in PAH	28/03
Cereno Scientific releases Insights Video Season 3 Episode 8 with Björn Dahlöf, CSO, Cereno Scientific	27/03
Cereno Scientific publishes Annual Report for 2023	26/03
Cereno Scientific participates at the upcoming medical conference ACC.24 to further build presence in the Cardiology community	25/03
Cereno Scientific Obtains New European Patent for Hypertension Drug Candidate	22/03
Cereno Scientific announces new patent issued in 25 European countries for Phase II drug candidate CS1	22/03
Cereno Scientific announces that a study protocol synopsis for the FDA approved Expanded Access Program for CS1 in PAH has been published on ClinicalTrials.gov	21/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cereno Scientific AB

Aandelen

CRNO B

SE0008241558

Andere talen

Filters